Table 1. Attitudes Toward COVID-19 and Influenza Vaccines Among a Nationally Representative Sample of US Adultsa.
Attitude | Participants, weighted % | |||
---|---|---|---|---|
All adults aged ≥18 y (n = 1430) | Only adults aged ≥50 y (n = 659) | |||
COVID-19 vaccine | Influenza vaccine | COVID-19 vaccine | Influenza vaccine | |
Effectivenessb | ||||
Very effective | 42 | 40 | 50 | 49 |
Somewhat effective | 28 | 38c | 25 | 35c |
Not too effective | 13c | 7 | 12c | 5 |
Not at all effective | 7c | 4 | 6 | 4 |
Safetyd | ||||
Very safe | 41 | 55c | 51 | 65c |
Somewhat safe | 29 | 29 | 24 | 23 |
Not too safe | 9c | 4 | 9c | 4 |
Not at all safe | 9c | 4 | 8c | 2 |
Vaccination intentionse | ||||
Very likely | 36 | 49c | 49 | 62c |
Somewhat likely | 18 | 15 | 15c | 9 |
Not too likely | 17c | 13 | 13c | 8 |
Not at all likely | 28c | 22 | 23 | 21 |
Data come from a July 2023 nationally representative, probability-based online and telephone survey of 1430 US adults aged 18 years and older. Weighted percentages are displayed and results may not add up to 100% because of rounding and because responses of “Don’t know” and “Refused” are included in the total but are not displayed. See eAppendix 1 and eAppendix 2 in Supplement 1 for methodological details.
The full question was, “In general, how effective are [COVID-19 vaccines/flu vaccines] for most adults in protecting the person getting vaccinated from getting seriously ill or having to be hospitalized with [COVID-19/the flu]?”
Value is significantly higher than comparison group (COVID-19 or influenza) at P < .05.
The full question was, “In general, how safe are [COVID-19 vaccines/flu vaccines] for most adults?”
The full question was, “Now imagine that, in the future, an updated COVID-19 vaccine or booster becomes available each year, and public health officials recommend all adults get it each fall. In this scenario, how likely would you be to get an updated COVID-19 vaccine this coming fall, in 2023? How likely are you to get a flu vaccine this coming flu season, which is expected to run from this October in 2023 to next April, in 2024?”